BAUSCH HEALTH COS INC (BHC.CA) Stock Fundamental Analysis

TSX:BHC • CA0717341071

7.96 CAD
-0.3 (-3.63%)
Last: Feb 12, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BHC. BHC was compared to 33 industry peers in the Pharmaceuticals industry. While BHC is still in line with the averages on profitability rating, there are concerns on its financial health. BHC is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year BHC was profitable.
  • BHC had a positive operating cash flow in the past year.
  • BHC had negative earnings in each of the past 5 years.
  • BHC had a positive operating cash flow in 4 of the past 5 years.
BHC.CA Yearly Net Income VS EBIT VS OCF VS FCFBHC.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

1.2 Ratios

  • The Return On Assets of BHC (1.35%) is better than 72.73% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 6.78%, BHC belongs to the top of the industry, outperforming 84.85% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for BHC is below the industry average of 8.74%.
  • The last Return On Invested Capital (6.78%) for BHC is above the 3 year average (5.45%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.35%
ROE N/A
ROIC 6.78%
ROA(3y)-1.07%
ROA(5y)-1.65%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.45%
ROIC(5y)4.93%
BHC.CA Yearly ROA, ROE, ROICBHC.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800

1.3 Margins

  • BHC has a better Profit Margin (3.61%) than 75.76% of its industry peers.
  • BHC's Operating Margin of 20.68% is amongst the best of the industry. BHC outperforms 84.85% of its industry peers.
  • BHC's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 70.67%, BHC belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
  • BHC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.68%
PM (TTM) 3.61%
GM 70.67%
OM growth 3Y1.02%
OM growth 5Y4.43%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.24%
GM growth 5Y-0.44%
BHC.CA Yearly Profit, Operating, Gross MarginsBHC.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • BHC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, BHC has more shares outstanding
  • Compared to 5 years ago, BHC has more shares outstanding
  • BHC has a better debt/assets ratio than last year.
BHC.CA Yearly Shares OutstandingBHC.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
BHC.CA Yearly Total Debt VS Total AssetsBHC.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

  • BHC has an Altman-Z score of 0.24. This is a bad value and indicates that BHC is not financially healthy and even has some risk of bankruptcy.
  • BHC's Altman-Z score of 0.24 is fine compared to the rest of the industry. BHC outperforms 63.64% of its industry peers.
  • The Debt to FCF ratio of BHC is 19.41, which is on the high side as it means it would take BHC, 19.41 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of BHC (19.41) is better than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 19.41
Altman-Z 0.24
ROIC/WACC1.03
WACC6.6%
BHC.CA Yearly LT Debt VS Equity VS FCFBHC.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

2.3 Liquidity

  • BHC has a Current Ratio of 1.30. This is a normal value and indicates that BHC is financially healthy and should not expect problems in meeting its short term obligations.
  • BHC's Current ratio of 1.30 is on the low side compared to the rest of the industry. BHC is outperformed by 69.70% of its industry peers.
  • A Quick Ratio of 0.97 indicates that BHC may have some problems paying its short term obligations.
  • BHC has a Quick ratio (0.97) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.97
BHC.CA Yearly Current Assets VS Current LiabilitesBHC.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 1.33% over the past year.
  • Measured over the past years, BHC shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.91% on average per year.
  • Looking at the last year, BHC shows a small growth in Revenue. The Revenue has grown by 5.86% in the last year.
  • BHC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.28% yearly.
EPS 1Y (TTM)1.33%
EPS 3Y-5.37%
EPS 5Y-2.91%
EPS Q2Q%2.65%
Revenue 1Y (TTM)5.86%
Revenue growth 3Y4.5%
Revenue growth 5Y2.28%
Sales Q2Q%6.81%

3.2 Future

  • Based on estimates for the next years, BHC will show a decrease in Earnings Per Share. The EPS will decrease by -3.58% on average per year.
  • The Revenue is expected to decrease by -0.40% on average over the next years.
EPS Next Y5.12%
EPS Next 2Y6.66%
EPS Next 3Y-1.71%
EPS Next 5Y-3.58%
Revenue Next Year6.13%
Revenue Next 2Y5.11%
Revenue Next 3Y3.03%
Revenue Next 5Y-0.4%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BHC.CA Yearly Revenue VS EstimatesBHC.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
BHC.CA Yearly EPS VS EstimatesBHC.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

9

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 1.53 indicates a rather cheap valuation of BHC.
  • Based on the Price/Earnings ratio, BHC is valued cheaper than 100.00% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.67. BHC is valued rather cheaply when compared to this.
  • A Price/Forward Earnings ratio of 1.37 indicates a rather cheap valuation of BHC.
  • Based on the Price/Forward Earnings ratio, BHC is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.69, BHC is valued rather cheaply.
Industry RankSector Rank
PE 1.53
Fwd PE 1.37
BHC.CA Price Earnings VS Forward Price EarningsBHC.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 81.82% of the companies in the same industry are more expensive than BHC, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, BHC is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2
EV/EBITDA 6.64
BHC.CA Per share dataBHC.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 -40 -60

4.3 Compensation for Growth

  • BHC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of BHC may justify a higher PE ratio.
PEG (NY)0.3
PEG (5Y)N/A
EPS Next 2Y6.66%
EPS Next 3Y-1.71%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for BHC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BAUSCH HEALTH COS INC

TSX:BHC (2/12/2026, 7:00:00 PM)

7.96

-0.3 (-3.63%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-29
Earnings (Next)02-18
Inst Owners45.78%
Inst Owner ChangeN/A
Ins Owners10.79%
Ins Owner ChangeN/A
Market Cap2.95B
Revenue(TTM)10.03B
Net Income(TTM)362.00M
Analysts48.89
Price Target10.2 (28.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.24%
Min EPS beat(2)-7.07%
Max EPS beat(2)2.59%
EPS beat(4)1
Avg EPS beat(4)-8.49%
Min EPS beat(4)-25.13%
Max EPS beat(4)2.59%
EPS beat(8)4
Avg EPS beat(8)-3.92%
EPS beat(12)7
Avg EPS beat(12)-2.32%
EPS beat(16)8
Avg EPS beat(16)-5.93%
Revenue beat(2)2
Avg Revenue beat(2)0.5%
Min Revenue beat(2)0.36%
Max Revenue beat(2)0.64%
Revenue beat(4)3
Avg Revenue beat(4)-0.05%
Min Revenue beat(4)-1.57%
Max Revenue beat(4)0.64%
Revenue beat(8)6
Avg Revenue beat(8)0.85%
Revenue beat(12)9
Avg Revenue beat(12)1.1%
Revenue beat(16)9
Avg Revenue beat(16)-0.08%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-0.59%
EPS NQ rev (3m)0.79%
EPS NY rev (1m)-0.19%
EPS NY rev (3m)-0.54%
Revenue NQ rev (1m)-0.4%
Revenue NQ rev (3m)-0.4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 1.53
Fwd PE 1.37
P/S 0.22
P/FCF 2
P/OCF 1.44
P/B N/A
P/tB N/A
EV/EBITDA 6.64
EPS(TTM)5.19
EY65.2%
EPS(NY)5.83
Fwd EY73.19%
FCF(TTM)3.97
FCFY49.88%
OCF(TTM)5.52
OCFY69.29%
SpS36.73
BVpS-2.07
TBVpS-61.1
PEG (NY)0.3
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.35%
ROE N/A
ROCE 9.41%
ROIC 6.78%
ROICexc 7.21%
ROICexgc 32.42%
OM 20.68%
PM (TTM) 3.61%
GM 70.67%
FCFM 10.81%
ROA(3y)-1.07%
ROA(5y)-1.65%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.45%
ROIC(5y)4.93%
ROICexc(3y)5.7%
ROICexc(5y)5.13%
ROICexgc(3y)40.1%
ROICexgc(5y)34.22%
ROCE(3y)7.57%
ROCE(5y)6.85%
ROICexgc growth 3Y34.27%
ROICexgc growth 5Y-5.74%
ROICexc growth 3Y14.02%
ROICexc growth 5Y12.75%
OM growth 3Y1.02%
OM growth 5Y4.43%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.24%
GM growth 5Y-0.44%
F-Score7
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 19.41
Debt/EBITDA 6.2
Cap/Depr 34.45%
Cap/Sales 4.21%
Interest Coverage 250
Cash Conversion 45.65%
Profit Quality 299.45%
Current Ratio 1.3
Quick Ratio 0.97
Altman-Z 0.24
F-Score7
WACC6.6%
ROIC/WACC1.03
Cap/Depr(3y)22.53%
Cap/Depr(5y)20.55%
Cap/Sales(3y)3.31%
Cap/Sales(5y)3.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.33%
EPS 3Y-5.37%
EPS 5Y-2.91%
EPS Q2Q%2.65%
EPS Next Y5.12%
EPS Next 2Y6.66%
EPS Next 3Y-1.71%
EPS Next 5Y-3.58%
Revenue 1Y (TTM)5.86%
Revenue growth 3Y4.5%
Revenue growth 5Y2.28%
Sales Q2Q%6.81%
Revenue Next Year6.13%
Revenue Next 2Y5.11%
Revenue Next 3Y3.03%
Revenue Next 5Y-0.4%
EBIT growth 1Y18.58%
EBIT growth 3Y5.56%
EBIT growth 5Y6.8%
EBIT Next Year16.54%
EBIT Next 3Y4.34%
EBIT Next 5Y-1.3%
FCF growth 1Y21.39%
FCF growth 3Y3.22%
FCF growth 5Y0.55%
OCF growth 1Y34.83%
OCF growth 3Y3.85%
OCF growth 5Y1.25%

BAUSCH HEALTH COS INC / BHC.CA FAQ

What is the ChartMill fundamental rating of BAUSCH HEALTH COS INC (BHC.CA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to BHC.CA.


Can you provide the valuation status for BAUSCH HEALTH COS INC?

ChartMill assigns a valuation rating of 9 / 10 to BAUSCH HEALTH COS INC (BHC.CA). This can be considered as Undervalued.


Can you provide the profitability details for BAUSCH HEALTH COS INC?

BAUSCH HEALTH COS INC (BHC.CA) has a profitability rating of 6 / 10.


Can you provide the financial health for BHC stock?

The financial health rating of BAUSCH HEALTH COS INC (BHC.CA) is 3 / 10.